市場調查報告書
商品編碼
1364779
全球醫院智慧型穿戴裝置市場預測(截至2030年)Smart Hospital Wearables Market Research Report Forecast to 2030 |
全球醫院智慧型穿戴裝置市場預計在預測期內將以 14.3% 的複合年增長率大幅成長。
北美市場是最大的市場,由於心血管疾病、惡性腫瘤和糖尿病等慢性疾病的主導地位日益增強,醫院可穿戴技術的進步以及深度本地化的醫療服務框架佔據了市場份額。
預計2022年至2030年亞太市場將以最高成長率發展。 這是由於人口老化的增加、醫療服務消費的增加以及人工智慧醫院穿戴式裝置的普及。 此外,代表亞洲龐大人口的工薪階層家庭的可支配收入不斷增加,並鼓勵人們在福利方面進行大量支出,正在推動該地區的市場發展。我是。
本報告研究分析了全球醫院智慧穿戴裝置市場,提供市場動態、區域和細分市場分析、公司簡介等。
The smart hospital wearables market is projected to register a significant CAGR of 14.3% during the forecast period. Expanded reception of smart hospital wearable gadgets to support market development. Smart hospital wearable gadgets are smart gadgets worn on the body that screen and track various crucial signs, for example, circulatory strain, pulse, and oxygen levels. These gadgets help in the observation of different ailments, for example, rest problems, diabetes, and lung illnesses. The blend of man-made reasoning (computer-based intelligence), AI, and digitalization in hospital wearable gadgets assists with continuous admittance to patient well-being information, worked on quiet results, and further developed proficiency and clinical staff limit. Besides, the developing reception of new advances and expanded web entrance set out open doors for the players associated with the market. Nonetheless, rising information security concerns and high gadget expenses might obstruct the Smart Hospital Wearables Market's development.
There are different advantages of smart hospital wearable gadgets. They are more useful to patients experiencing persistent sicknesses, as these patients are bound to get long-haul clinical consideration and are bound to visit trauma centers. These smart wearable gadgets are coordinated with state-of-the-art innovations like the Web of Things, permitting medical services experts to screen patients and give more far-reaching care. There are different sorts of smart hospital wearable gadgets, for example, wearable biosensors, wearable ECG screens, and wearable circulatory strain screens.
Diagnostic & monitoring devices and therapeutic devices are included in the market segments for smart hospital wearables. The vital sign monitoring devices, blood glucose monitoring devices, neuromonitoring devices, sleep monitoring devices, and others subsegment the diagnostic & monitoring devices market. The therapeutic devices category is further broken down into sub-segmented respiratory therapy, rehabilitation, pain management, and other uses.
The market is divided into categories based on technology including cloud computing, artificial intelligence, and the Internet of Things.
The global market for smart hospital wearables has been divided into three categories based on distribution channels: pharmacies, hypermarkets, and online.
The development of the North American smart hospital wearables market is credited to mechanical progressions in hospital wearable gadgets and the deep-rooted medical services foundation in the region.
North American market of smart hospital wearables represents the biggest piece of the pie because of the expanded predominance of ongoing illnesses like cardiovascular problems, malignant growth, and diabetes, mechanical progressions in hospital wearable gadgets, and deep-rooted medical services framework in the region.
The Asia-Pacific smart hospital wearables market is supposed to develop at most elevated rate from 2022 to 2030. This is because of the rising geriatric populace, the ascent in medical services consumption, and the rising reception of artificial intelligence-empowered hospital wearables. Besides, the rising extra cash of working-class families, which represent a huge populace in Asia, empowering serious spending on wellbeing, is driving the market development of smart hospital wearables in the region.
The key players in the market are Boston Scientific Corporation (US), Sotera, Inc. (US), Omron Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), MediaTek Health Systems (India), VitalConnect (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Honeywell International Inc. (US), and BioIntelliSense, Inc. (US).
TABLE OF CONTENTS